ESMA Recognizes CME Group Benchmark Administration as a Third-Country Benchmark Administrator

Rhea-AI Summary

CME Group (NASDAQ:CME) announced on April 16, 2026 that the European Securities and Markets Authority ESMA recognized CME Group Benchmark Administration as a third-country benchmark administrator under the EU Benchmarks Regulation.

This recognition secures continued use of CME Term SOFR by EU clients and cites >€100B of European OTC derivatives referencing the rates in 2025, $1.3T globally, and $11T in active commercial loans.

Positive

• ESMA recognition enables continued EU use of CME Term SOFR
• Referenced in over €100B of European OTC derivatives in 2025
• Referenced in $1.3T of global OTC derivatives
• Referenced in $11T of active commercial loans

Negative

• None.

News Market Reaction – CME

-0.23%

1 alert

-0.23% News Effect

On the day this news was published, CME declined 0.23%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

OTC derivatives notional (EU): €100B Global derivatives notional: $1.3T Active commercial loans: $11T

3 metrics

OTC derivatives notional (EU) €100B CME Term SOFR use by European participants in 2025

Global derivatives notional $1.3T CME Term SOFR use globally in 2025

Active commercial loans $11T Loans referencing CME Term SOFR Reference Rates

Market Reality Check

Price: $287.65 Vol: Volume 1,205,784 is about...

low vol

$287.65 Last Close

Volume Volume 1,205,784 is about 45% below the 20-day average of 2,197,073, indicating subdued trading ahead of this news. low

Technical Trading above the 200-day MA of 281.06 and about 9.8% below the 52-week high of 329.16.

Peers on Argus

CME was roughly flat at -0.04% while key peers like ICE, NDAQ, MCO and SPGI gain...

CME was roughly flat at -0.04% while key peers like ICE, NDAQ, MCO and SPGI gained between 0.84% and , and COIN rose 5.58%, suggesting today’s setup was more stock-specific than sector-driven.

Historical Context

5 past events · Latest: Apr 15 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Apr 15	Dividend products expansion	Positive	-0.0%	Expanded equity index dividend suite with new mid-curve options and futures.
Apr 14	Rate product launch	Positive	-1.2%	Planned launch of options on Eris SOFR Swap futures across key maturities.
Apr 08	Record ADV update	Positive	-2.5%	Reported record Q1 2026 international and global average daily volume growth.
Apr 07	Ag sentiment index	Positive	+0.7%	Purdue/CME Ag Economy Barometer showed improving farmer sentiment and expectations.
Apr 07	Crypto futures expansion	Positive	+0.7%	Announced new Avalanche and Sui futures and 24/7 crypto trading expansion.

Pattern Detected

Recent product and volume-related announcements have often been positive in tone but followed by mixed to negative next-day price moves, indicating a pattern of muted or contrarian reactions to good news.

Recent Company History

Over the last few weeks, CME has focused on product expansion and record activity. Announcements included new equity index dividend products (Apr 15), Eris SOFR swap options (Apr 14), and record Q1 2026 international ADV of 11.4M contracts (Apr 8). Crypto futures expansion and improved farmer sentiment were also highlighted. Despite generally positive fundamentals, share reactions have alternated between modest gains and declines, framing today’s ESMA benchmark recognition within a history of constructive news but inconsistent price responses.

Market Pulse Summary

This announcement details ESMA’s recognition of CME Group Benchmark Administration as a third-countr...

Analysis

This announcement details ESMA’s recognition of CME Group Benchmark Administration as a third-country benchmark administrator under EU BMR, formally supporting continued European use of CME Term SOFR. The benchmark underpins over €100B of European OTC derivatives, $1.3T globally, and $11T in active loans. In the past six months CME has repeatedly reported product expansions and record volumes, so investors may watch how this regulatory milestone fits into that broader growth trajectory and client adoption trends.

Key Terms

eu benchmarks regulation, otc derivatives, central counterparty clearing

3 terms

eu benchmarks regulation regulatory

"as a third-country benchmark administrator under the EU Benchmarks Regulation (EU BMR)"

A set of EU rules that governs how financial benchmarks — the indexes or reference numbers used to price loans, investments and funds — are created, managed and overseen. Think of it as rules for a common yardstick: it forces benchmark providers to follow clear procedures, reduces the risk of manipulation, and gives investors confidence that prices and valuations tied to those benchmarks are reliable and subject to official oversight.

otc derivatives financial

"In 2025, the rates were referenced in over €100B of OTC derivatives traded"

Over‑the‑counter (OTC) derivatives are private financial contracts—like swaps, forwards or options—made directly between two parties instead of through a public exchange. They matter to investors because these deals are highly customizable (like tailoring a suit) but carry greater credit and liquidity risk: the other party might not perform and it can be hard to sell the contract, so OTC positions can amplify gains or losses and affect a firm’s financial health.

central counterparty clearing technical

"it operates one of the world's leading central counterparty clearing providers, CME Clearing"

A central counterparty clearing (CCP) is a specialized financial intermediary that sits between buyers and sellers of securities or derivatives, becoming the buyer to every seller and the seller to every buyer to guarantee trades are completed. Like an insurance-backed referee, it manages the risk of someone failing to pay by requiring collateral, pooling resources, and simplifying many trades into smaller net payments, which helps investors by lowering the chance of loss from a counterparty default and improving market stability and liquidity.

AI-generated analysis. Not financial advice.

LONDON and CHICAGO, April 16, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that the European Securities and Markets Authority (ESMA) has recognized CME Group Benchmark Administration Limited (CBA) as a third-country benchmark administrator under the EU Benchmarks Regulation (EU BMR).

ESMA's decision was made in response to the significant usage of CME Term SOFR Reference Rates by market participants in Europe. The decision provides certainty for clients subject to EU BMR.

"This recognition underscores the significant role played by CME Term SOFR for European institutions managing USD interest rate exposure," said Max Ruscher, Global Head of Benchmark Administration at CME Group. "Most importantly, it ensures European institutions can continue to use the benchmark without disruption, reinforcing our commitment to delivering transparent and reliable reference rates that clients depend upon." 

CME Term SOFR Reference Rates are the global benchmark for commercial U.S. dollar lending. It is the first and only benchmark to be formally endorsed by the Alternative Reference Rates Committee (ARRC). 

In 2025, the rates were referenced in over €100B of OTC derivatives traded by European participants and $1.3T globally.* They are referenced in $11T of active commercial loans.**

For more information about CME Term SOFR Reference Rates visit www.cmegroup.com/termsofr 

* Source: SBSDRView from Clarus.
**Source: Refinitiv Deals Screener.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. 

CME-G

 

View original content:https://www.prnewswire.com/news-releases/esma-recognizes-cme-group-benchmark-administration-as-a-third-country-benchmark-administrator-302744070.html

SOURCE CME Group

FAQ

What does ESMA recognition mean for CME Group (CME) and European clients?

It permits European institutions to continue using CME Term SOFR without regulatory disruption. According to the company, ESMA recognized CME Group Benchmark Administration as a third-country administrator under EU BMR, providing legal certainty for EU market usage and compliance.

When did ESMA recognize CME Group Benchmark Administration as a third-country administrator?

ESMA recognition was announced on April 16, 2026. According to the company, this decision responds to significant European usage of CME Term SOFR and clarifies its status under the EU Benchmarks Regulation for market participants.

How widely is CME Term SOFR referenced by European participants in 2025?

In 2025, European participants referenced CME Term SOFR in over €100 billion of OTC derivatives. According to the company, that figure reflects significant adoption across euro-area derivative markets and supports ESMA's recognition decision.

What is the global scale of instruments referencing CME Term SOFR?

CME Term SOFR was referenced in $1.3 trillion of OTC derivatives globally and $11 trillion of active commercial loans. According to the company, these metrics show broad international reliance on the benchmark across lending and derivatives.

Does ESMA recognition change the governance or endorsement status of CME Term SOFR?

Recognition affirms third-country administrator status under EU BMR but does not alter prior endorsements. According to the company, CME Term SOFR remains the ARRC-endorsed benchmark and continues under existing governance and publication practices.